Clinical trial
Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or…
NCT00085306 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00085306 |
|---|---|
| Title | Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma |
| Official title | Phase II Trial Of Interferon-B In Patients With Metastatic Cutaneous Melanoma And Metastatic Ocular Melanoma |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage IV Melanoma, Recurrent Melanoma |
| Intervention type | Biological |
| Interventions | recombinant interferon beta |
| Enrollment | 21 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jun 11, 2004 |
| Last update posted | Oct 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: